Remel Bile Esculin Azide Agar W/6 Mcg/Ml Vancomycin
by Remel, L.P.
510(k) K972359
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK972359 | Date28 Aug 1997 | StatusActive |
Recalls
-
- Terminated Z-1561-2021
The media allows growth of E. faecalis ATCC 29212 with blackening of the media.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JSO
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1700
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
This is a selective and differential culture medium classified as an antimicrobial susceptibility test medium, excluding Mueller Hinton Agar. Remel Bile Esculin Azide Agar with 6 mcg/mL Vancomycin is designed to isolate and presumptively identify vancomycin-resistant enterococci (VRE) from clinical samples. The medium incorporates sodium azide and oxgall to inhibit Gram-negative bacteria, while vancomycin selectively targets resistant enterococcal strains. Esculin hydrolysis aids in differentiating group D streptococci, including enterococci, from other organisms.
The medium is supplied as a dehydrated powder for laboratory preparation and is intended for single-use in clinical microbiology settings. It is not sterile upon receipt and requires reconstitution with sterile distilled water or another appropriate medium. The product is regulated under FDA 510(k) clearance (K972359) and falls under device class II (866.1700). Storage should follow manufacturer guidelines for dehydrated culture media, typically in a cool, dry place protected from light until use.
Other devices from Remel, L.P.
Questions
AI-generated answers, 1 Oct 2026
What is Remel Bile Esculin Azide Agar with 6 mcg/mL Vancomycin used for?
This medium is designed to isolate and presumptively identify vancomycin-resistant enterococci (VRE) from clinical samples. It uses sodium azide and oxgall to suppress Gram-negative bacteria while vancomycin selectively targets resistant enterococcal strains. Esculin hydrolysis further differentiates group D streptococci, including enterococci, from other organisms.
How is Remel Bile Esculin Azide Agar with Vancomycin supplied and prepared?
The product is supplied as a dehydrated powder for laboratory preparation. It is not sterile upon receipt and must be reconstituted with sterile distilled water or another appropriate medium before use. It is intended for single-use in clinical microbiology settings.
Is this medium sterile when received, and what are the storage instructions?
No, the medium is not sterile upon receipt. It requires reconstitution with sterile water or an appropriate medium before use. Storage should follow manufacturer guidelines, typically in a cool, dry place protected from light until use.
Can this medium be reused after preparation?
No, Remel Bile Esculin Azide Agar with Vancomycin is intended for single-use only. Each preparation should be discarded after use to maintain accuracy and prevent contamination.
What regulatory pathway does this product follow?
This product is regulated under FDA 510(k) clearance with the clearance number K972359. It falls under device class II (866.1700) and is classified as an antimicrobial susceptibility test medium, excluding Mueller Hinton Agar.